BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 9227340)

  • 1. The spectrum of 67-kD laminin receptor expression in breast carcinoma progression.
    Viacava P; Naccarato AG; Collecchi P; Ménard S; Castronovo V; Bevilacqua G
    J Pathol; 1997 May; 182(1):36-44. PubMed ID: 9227340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of the 67-kD laminin receptor correlates with tumour progression in human colorectal carcinoma.
    Sanjuán X; Fernández PL; Miquel R; Muñoz J; Castronovo V; Ménard S; Palacín A; Cardesa A; Campo E
    J Pathol; 1996 Aug; 179(4):376-80. PubMed ID: 8869283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 67-kDa laminin receptor in human laryngeal squamous cell carcinoma.
    Zhou L; Xie M; Zhou JQ; Tao L
    Laryngoscope; 2006 Jan; 116(1):28-32. PubMed ID: 16481804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenesis and VEGF expression in pre-invasive lesions of the human breast.
    Viacava P; Naccarato AG; Bocci G; Fanelli G; Aretini P; Lonobile A; Evangelista G; Montruccoli G; Bevilacqua G
    J Pathol; 2004 Oct; 204(2):140-6. PubMed ID: 15376259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different proliferative patterns characterize different preinvasive breast lesions.
    Viacava P; Naccarato AG; Bevilacqua G
    J Pathol; 1999 Jul; 188(3):245-51. PubMed ID: 10419590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 67 kDa laminin receptor increases tumor aggressiveness by remodeling laminin-1.
    Berno V; Porrini D; Castiglioni F; Campiglio M; Casalini P; Pupa SM; Balsari A; Ménard S; Tagliabue E
    Endocr Relat Cancer; 2005 Jun; 12(2):393-406. PubMed ID: 15947111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the patterns of laminin expression in fibroadenoma, fibrocystic diseases, pre-invasive and invasive ductal breast carcinoma.
    Zheng WQ; Looi LM; Cheah PL
    Pathology; 2001 Aug; 33(3):303-6. PubMed ID: 11523929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of types XV and XIX collagen precedes basement membrane invasion in ductal carcinoma of the female breast.
    Amenta PS; Hadad S; Lee MT; Barnard N; Li D; Myers JC
    J Pathol; 2003 Mar; 199(3):298-308. PubMed ID: 12579531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of Fhit protein is related inversely to disease progression in patients with breast carcinoma.
    Gatalica Z; Lele SM; Rampy BA; Norris BA
    Cancer; 2000 Mar; 88(6):1378-83. PubMed ID: 10717620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H; Stephens LC; Kumar R
    Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear cytometric changes in breast carcinogenesis.
    Mommers EC; Poulin N; Sangulin J; Meijer CJ; Baak JP; van Diest PJ
    J Pathol; 2001 Jan; 193(1):33-9. PubMed ID: 11169513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the 67 KD laminin receptor in human cervical preneoplastic and neoplastic squamous epithelial lesions: an immunohistochemical study.
    al-Saleh W; Delvenne P; van den Brule FA; Menard S; Boniver J; Castronovo V
    J Pathol; 1997 Mar; 181(3):287-93. PubMed ID: 9155714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p27/kip1 expression in normal epithelium, benign and neoplastic breast lesions.
    De Paola F; Vecci AM; Granato AM; Liverani M; Monti F; Innoceta AM; Gianni L; Saragoni L; Ricci M; Falcini F; Amadori D; Volpi A
    J Pathol; 2002 Jan; 196(1):26-31. PubMed ID: 11748638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MnSOD expression is less frequent in tumour cells of invasive breast carcinomas than in in situ carcinomas or non-neoplastic breast epithelial cells.
    Soini Y; Vakkala M; Kahlos K; Pääkkö P; Kinnula V
    J Pathol; 2001 Sep; 195(2):156-62. PubMed ID: 11592093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal, hyperplastic, and neoplastic human breast.
    Clezardin P; Frappart L; Clerget M; Pechoux C; Delmas PD
    Cancer Res; 1993 Mar; 53(6):1421-30. PubMed ID: 7680285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression of galectin-3 is associated with progression of human breast cancer.
    Castronovo V; Van Den Brûle FA; Jackers P; Clausse N; Liu FT; Gillet C; Sobel ME
    J Pathol; 1996 May; 179(1):43-8. PubMed ID: 8691344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis.
    Lee AH; Dublin EA; Bobrow LG; Poulsom R
    J Pathol; 1998 Aug; 185(4):394-401. PubMed ID: 9828838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase of GKLF messenger RNA and protein expression during progression of breast cancer.
    Foster KW; Frost AR; McKie-Bell P; Lin CY; Engler JA; Grizzle WE; Ruppert JM
    Cancer Res; 2000 Nov; 60(22):6488-95. PubMed ID: 11103818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth stimulatory angiotensin II type-1 receptor is upregulated in breast hyperplasia and in situ carcinoma but not in invasive carcinoma.
    De Paepe B; Verstraeten VL; De Potter CR; Vakaet LA; Bullock GR
    Histochem Cell Biol; 2001 Sep; 116(3):247-54. PubMed ID: 11685554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
    Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.